Actively Recruiting
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Led by Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Updated on 2025-12-22
104
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of IBI112 in the treatment of adolescent participants with moderate to severe plaque-type psoriasis.
CONDITIONS
Official Title
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females aged 12 to 18 years
- Diagnosed with plaque psoriasis and a history of psoriasis 6 months
- Suitable for phototherapy and/or systemic treatment for psoriasis
You will not qualify if you...
- History or current signs of severe, progressive, or uncontrolled major organ or psychiatric disease
- History of erythrodermic, pustular, medication-induced/exacerbated, or new onset guttate psoriasis
- Use of IL-17 targeted therapy within 6 months before study
- Use of TNF-alpha targeted therapy within 3 months before study
- Use of conventional therapy within 1 month before study
- Use of topical therapy within 2 weeks before study
- Previous treatment with IBI112
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Children's Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China, 100000
Actively Recruiting
Research Team
B
Bingjing Feng
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here